| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/11/2002 | EP1239039A1 Novel polypeptide and dna thereof |
| 09/11/2002 | EP1238979A1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same |
| 09/11/2002 | EP1238971A1 Substituted guanidine derivatives |
| 09/11/2002 | EP1238670A1 Composition and method for treating and preventing cardiovascular disease and hypertension. |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238016A1 Substituted phthalocyanines and their precursors |
| 09/11/2002 | EP1237917A2 Protein c derivatives |
| 09/11/2002 | EP1237902A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 09/11/2002 | EP1237898A2 N?6 heterocyclic 8-modified adenosine derivatives |
| 09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/11/2002 | EP1237890A1 Synthesis and methods of use of 9-substituted guanine derivatives |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 09/11/2002 | EP1237886A1 Heterocyclic derivatives |
| 09/11/2002 | EP1237880A2 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 09/11/2002 | EP1237877A2 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 09/11/2002 | EP1237876A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
| 09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 09/11/2002 | EP1237859A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 09/11/2002 | EP1237856A1 New tri-substituted phenyl derivatives and analogues |
| 09/11/2002 | EP1237855A1 Crystalline form of (s)-2 ethoxy-3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid |
| 09/11/2002 | EP1237854A1 Comminuted form of (s)-2-ethoxy -3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP1237845A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/11/2002 | EP1237578A2 Micro-cluster liquids and methods of making and using them |
| 09/11/2002 | EP1237577A2 Transmucosal composition containing a phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 09/11/2002 | EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 09/11/2002 | EP1237558A1 Novel helicobacter pylori-binding substances and use thereof |
| 09/11/2002 | EP1237550A2 Methods for treating cell death diseases and inflammation |
| 09/11/2002 | EP1237548A1 Il-8 receptor antagonists |
| 09/11/2002 | EP1237544A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 09/11/2002 | EP0944614B1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/11/2002 | EP0876367B1 Trans apovincaminic acid ester derivatives as drugs |
| 09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/11/2002 | EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 09/11/2002 | EP0699070B1 Aurintricarboxylic acid fractions and analogues with anti-angiogenic activity and methods of use |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
| 09/11/2002 | CN1368963A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 09/11/2002 | CN1368962A Fluorene derivatives |
| 09/11/2002 | CN1368961A Compounds for modulation of PPAP gamma activity |
| 09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 09/11/2002 | CN1368959A Prostaglandin derivatives |
| 09/11/2002 | CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 09/11/2002 | CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha |
| 09/11/2002 | CN1368950A Novel aminobenzophenones |
| 09/11/2002 | CN1368892A Sustained release formulation of peptide |
| 09/11/2002 | CN1368884A Method for modulating FXR receptor activity |
| 09/11/2002 | CN1368881A Use of inhibitors of renin-angiotensin systemin prevention of cardiovascular events |
| 09/11/2002 | CN1368879A Use of (-)(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/11/2002 | CN1368874A Implantable active ingredient depot |
| 09/11/2002 | CN1368853A Prophylactic dietary supplement based on milk |
| 09/11/2002 | CN1368503A Safflower lyochrome rich in carthamin A, its preparing process, its preparation and its medical usage |
| 09/11/2002 | CN1368499A Dihydropyridine derivative with structure of guaiacoxypropanol amine and phenoxypropanol amine |
| 09/11/2002 | CN1368377A Zhixuening capsule and its preparing process |
| 09/11/2002 | CN1368373A Chinese medicine for treating bone tuberculosis, osteomyelitis, phlebitis and organism ulceration |
| 09/11/2002 | CN1368352A Nano medicine 'Guanxinning' and its preparing process |
| 09/11/2002 | CN1368346A Nano emdicine 'Jiuerxin' and its preparing process |
| 09/11/2002 | CN1368338A Nano medicine 'Quick-acting Xintong' and its preparing process |
| 09/11/2002 | CN1368316A Nano medicine 'Shuxinjangzhi' and its preparing process |
| 09/11/2002 | CN1368307A Nano medicine 'Yinaoning' and its preparing process |
| 09/11/2002 | CN1368301A Nano medicine 'Xinshujing' and its preparing process |
| 09/11/2002 | CN1368300A Nano medicine 'Xintongning' and its preparing process |
| 09/11/2002 | CN1368295A Nano medicine 'Xiangdan' and its preparing process |
| 09/11/2002 | CN1368282A Nano medicine 'Zhitejia' and its preparing process |
| 09/11/2002 | CN1368270A Nano medicine 'Sanqi Huazhi' and its preparing process |
| 09/11/2002 | CN1368251A Nano medicine 'Changchunbao' and its preparing process |
| 09/11/2002 | CN1368171A Nano medicine 'Zhenzhu Lingzhu' and its preparing process |
| 09/11/2002 | CN1368133A Nano medicine for treating laugh inability and its preparing process |
| 09/11/2002 | CN1368131A Nano medicine 'Shexiangkangshuan' and its preparing process |
| 09/11/2002 | CN1368121A Nano medicine 'Jinzeguanxin' and its preparing process |
| 09/11/2002 | CN1368116A Nano medicine 'Yangxin Dingji' and its preparing process |
| 09/11/2002 | CN1368087A Nano medicine for treating cerebral thrombus and its preparing process |
| 09/11/2002 | CN1368077A Nano whole eucommia meidicne and its preparing process |
| 09/11/2002 | CN1368074A Nano medicine 'Tongmai Jiangzhi' and its preparing process |
| 09/11/2002 | CN1368061A Nano meidcine 'Xiaoshuan Tongluo' and its preparing process |
| 09/11/2002 | CN1368054A Process for preparing soft body of pearl shell as Chinese-medicinal material |
| 09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
| 09/11/2002 | CN1090631C Heterocyclic compounds, preparation process thereof and medicinal composition containing same |
| 09/11/2002 | CN1090630C Preparation of [1S-[1a, 2b, 3b, 4a(S*)]]-4-[7-[1-(3-chloro-2-thienyl)methyl]propyl]amino]-3H-imidazo [4,5-b] pyridin-3-yl]-N-ethyl-2,3-dyhydroxy pentamethylene formamide |
| 09/11/2002 | CN1090628C New N-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/11/2002 | CN1090490C Traditional Chinese medicine health care pillow |
| 09/11/2002 | CN1090483C Potassium and magnesium controlled-release tablet and producing method thereof |
| 09/10/2002 | US6448429 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| 09/10/2002 | US6448397 Treating central nervous system diseases with modulation of 5-ht activity; adrenergic, dopaminergic, and serotonergic neurotransmitters; psychosis, paraphrenia, depression, mania, schizophrenia, anxiety, migraine headache, drug addiction |
| 09/10/2002 | US6448292 Comprising a diglyceride in which at least 55% by weight of constitutive acyl groups are unsaturated acyl groups and 15 to 100% by weight thereof are omega 3 type unsaturated acyl groups having at least 20 carbon atoms and a triglyceride |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448275 Side effect reduction |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448272 Myt1 kinase inhibitors |
| 09/10/2002 | US6448271 Substituted benzimidazoles and their use as parp inhibitors |
| 09/10/2002 | US6448267 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/10/2002 | US6448253 Adenosine A3 receptor modulators |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |